Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumorsJ. Norenberg, T. Anderson, J. Hesterman, K. Orcutt, M. Nysus, D. Kusewitt, J. Fair,H. Soares,K. John,O. RixeNuclear Medicine and Biology（2019）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
